Merge Healthcare Incorporated (Nasdaq:MRGE), a leading provider of clinical systems and innovations that seek to transform healthcare, today announced that Merge Cardio(TM) has been named Best in KLAS for the cardiology software category within the "2013 Best in KLAS: Software & Services" report. In addition, Merge Hemo(TM) has been named the Category Leader in Cardiology Hemodynamics for the third successive year.

"We're excited that not only has Merge Hemo retained its number one status as Category Leader for the third straight year, but Merge Cardio has received the Best in KLAS top honor this year, as well. We believe that both of these designations speak to our ongoing diligence in developing superior clinical solutions to meet our client's needs," said Justin Dearborn, CEO of Merge Healthcare. "What's more, we're honored to be the first vendor to receive top recognition from KLAS for both cardiology categories, and feel that this solidifies Merge's leadership status in the CVIS market."

Combined, Merge Hemo and Merge Cardio provide a seamless solution for advanced reporting and enhanced workflow. Currently running in over 500 cardiac cath labs in some of the country's largest health systems, Merge Hemo captures real-time data and documents procedural events to enable efficient workflow. Merge Cardio, implemented in over 200 organizations, is a web-enabled enterprise-level image and information system that provides a single point of entry to the patient's complete cardio record spanning all cardiac modalities.